Preparation method of natural ester lyngbyabellin O
Through segmented synthesis and modular design, the problems of by-products and stereoisomers in lyngbyabellin O synthesis are solved, the reaction success rate and efficiency are improved, and the preparation of natural ester lyngbyabellin O is achieved.
Patent Information
- Application Number
- CN202411430301.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-14
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The presence of by-products and incorrect stereoisomers during the synthesis of natural esters lyngbyabellin O, leads to complex reaction selectivity and purification steps and inefficient efficiency.
Lyngbyabellin O was disassembled into two thiazole fragments and one dichloro fragment, and functional groups and structural units were gradually introduced through segmented synthesis strategy, and the target molecules were gradually assembled using modular design and optimization of reaction conditions.
It improves the overall reaction success rate and synthesis efficiency, reduces the complexity of each step, enhances the operability of the synthesis process, and is suitable for laboratory and industrial production.
Smart Images

Figure CN118930496A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of synthetic chemistry, and in particular relates to a preparation method of natural ester lyngbyabellin O. Background Art
[0002] The ester natural product lyngbyabellin O with excellent antifouling activity was discovered by Professor Okino's research group at Hokkaido University in 2017. Given that lyngbyabellin O represents a new type of antifouling active compound, in-depth synthesis and structure-activity relationship research on lyngbyabellin O is of great significance for the development of new antifouling molecules. In the antifouling test of lyngbyabellin O on Amphibalanus amphitrite larvae, the EC50 value of the compound was 0.38 µM, which is a very strong antifouling active molecule. At the same time, the compound also has a certain cytotoxicity, with a GI50 of greater than 160 µM. Due to the excellent activity of this type of compound, the synthesis and activity research of this type of molecule has never stopped since its isolation in 2019.
[0003] Due to the presence of multiple adjacent chiral centers and sensitive functional groups in the Lyngbyabellin O molecule, byproducts or incorrect stereoisomers are easily produced during the synthesis process. The relevant technology has difficulties in controlling the stereoselectivity and regioselectivity of the reaction, making it difficult to obtain the desired pure product. Moreover, since each step of the reaction may have side reactions or incomplete reactions, the purification steps become complicated and time-consuming, which makes the overall synthesis process inefficient. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a method for preparing natural ester lyngbyabellin O, aiming to solve the problem that the synthesis of natural ester lyngbyabellin O is difficult and inefficient.
[0005] To solve the above technical problems, the present invention is implemented as follows: a method for preparing a natural ester lyngbyabellin O, comprising the steps of: S1. preparing compound 8; S2, compound 9 and compound 10 undergo condensation reaction to obtain compound 14; S3, compound 15 and compound 16 undergo dehydration cyclization reaction to obtain compound 18; S4, the compound 14 and the compound 18 are first subjected to an esterification reaction, and then the compound 8 is added to carry out an esterification reaction to obtain the compound 22, wherein the compound 22 is a natural ester lyngbyabellin O; Wherein, the structural formula of the above compound is as follows: , , , , , , , .
[0006] In some embodiments of the present invention, step S1 comprises: S1.1, mixing compound 2 and compound 4 in an alkaline environment, adding a catalyst, to obtain compound 5; S1.2, the compound 5 is subjected to a dehydration cyclization reaction to obtain a compound 6; S1.3, the compound 6 is first oxidized to form the compound 7, and then the compound 7 is subjected to an asymmetric dihydroxylation reaction to generate the compound 8; Wherein, the structural formula of the above compound is as follows: , , , , .
[0007] In some embodiments of the present invention, the synthesis steps of compound 2 include: Compound 1 is placed in an alkaline environment to undergo a substitution reaction with methyl iodide to generate a methyl ester group; Add diethylamine to the compound 1 to remove the protecting group to generate the compound 2; Wherein, the structural formula of the above compound is as follows: .
[0008] In some embodiments of the present invention, step S1 comprises: After dissolving compound 25, triethylamine was added, and then a chloromethylation reagent was added to obtain compound 26; Compound 27 undergoes a nucleophilic substitution reaction with the compound 26 to obtain compound 28; Dissolving the compound 28 in an inert solvent, adding an oxidant to convert the chloro group into a hydroxyl group, thereby obtaining the compound 8; Wherein, the structural formula of the above compound is as follows: , , , .
[0009] In some embodiments of the present invention, the steps of preparing the compound 25 include: Dissolve L-ethionine and ethyl cyanoacetate in anhydrous ethanol, add an alkaline reagent and heat to react to generate compound 3; The compound 3 is dissolved in anhydrous methanol, an acidic reagent is added to carry out a heating reaction, and after the reaction is completed, an alkaline reagent is added to neutralize the reaction to obtain the compound 25; Wherein, the structural formula of the above compound is as follows: .
[0010] In some embodiments of the present invention, step S2 includes: S2.1, adding Lewis acid to the compound 9 and the compound 10 to carry out a condensation reaction to obtain a compound 11; S2.2, adding diethyl azodicarboxylate, triphenylphosphine and p-nitrobenzoic acid to the compound 11 in sequence to carry out a bimolecular nucleophilic substitution reaction to obtain compound 12; S2.3, adding lithium hydroxide and hydrogen peroxide to the compound 12, removing the chiral auxiliary group and performing ester hydrolysis reaction to obtain compound 13; S2.4, adding allyl bromide and potassium bicarbonate to the compound 13 to obtain the compound 14; Wherein, the structural formula of the above compound is as follows: , , .
[0011] In some embodiments of the present invention, step S3 includes: S3.1, dissolving and mixing the compound 15 and the compound 16, adding triethylamine, and stirring to react; S3.2, adding acetonitrile and manganese dioxide, heating and stirring, filtering, washing and concentrating in sequence to obtain compound 17; S3.3, mixing the compound 17 with a lithium hydroxide solution, and performing a hydrolysis reaction to generate the compound 18; Wherein, the structural formula of the above compound is as follows: .
[0012] In some embodiments of the present invention, step S4 includes: S4.1, adding N,N'-dicyclohexylcarbodiimide and 4-dimethylaminopyridine to the compound 14 and the compound 18 to carry out an esterification reaction to generate a compound 19; S4.2, adding tetrakistriphenylphosphine palladium and morpholine to the compound 19, removing the allyl ester, and obtaining the compound 20; S4.3, the compound 20 and the compound 8 undergo esterification reaction to obtain compound 21; S4.4, adding trifluoroacetic acid to the compound 21 to remove the protecting group to obtain the compound 22; Wherein, the structural formula of the above compound is as follows: , , .
[0013] Compared with the prior art, the preparation method of the natural ester lyngbyabellin O in the present invention has the following beneficial effects: The present invention disassembles the natural ester lyngbyabellin O into two thiazole fragments and a dichloro fragment according to the structural characteristics, and divides the entire synthesis process into multiple steps, each of which is modified and constructed for a specific compound or functional group. This segmented synthesis strategy can effectively reduce the complexity of each step, gradually introduce the required functional groups and structural units, and help improve the success rate and synthesis efficiency of the overall reaction. Each compound is a module, and the target molecule is constructed by gradually assembling these modules. This modular design can flexibly adjust the reaction steps to optimize the overall synthesis route. The staged reaction design and optimized reaction conditions make the entire synthesis process highly operable, which is of great significance for laboratory synthesis and future industrial amplification. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 The figure is a schematic flow chart of a method for preparing the natural ester lyngbyabellin O in one embodiment of the present invention. DETAILED DESCRIPTION
[0015] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0016] Please refer to Figure 1 The present invention provides a method for preparing a natural ester lyngbyabellin O, the steps comprising: S1. preparing compound 8; S2, compound 9 and compound 10 undergo condensation reaction to obtain compound 14; S3, compound 15 and compound 16 undergo dehydration cyclization reaction to obtain compound 18; S4, compound 14 and compound 18 are first subjected to esterification reaction, and then compound 8 is added for esterification reaction to obtain compound 22. Compound 22 is a natural ester lyngbyabellin O.
[0017] The present invention disassembles the natural ester lyngbyabellin O into two thiazole fragments and a dichloro fragment according to the structural characteristics, and divides the entire synthesis process into multiple steps, each of which is modified and constructed for a specific compound or functional group. This segmented synthesis strategy can effectively reduce the complexity of each step, gradually introduce the required functional groups and structural units, and help improve the success rate of the overall reaction. Each compound is a module, and the target molecule is constructed by gradually assembling these modules. This modular design can flexibly adjust the reaction steps to optimize the overall synthesis route. The staged reaction design and optimized reaction conditions make the entire synthesis process highly operable, which is of great significance for laboratory synthesis and future industrial amplification.
[0018] The synthesis of compound 8 is the initial step of the entire synthetic route, which provides a key intermediate containing a carboxylate group. This intermediate will play an important role in the subsequent esterification reaction, so its synthesis quality and purity directly affect the quality of the final product and provide a basic skeleton for the final structure of lyngbyabellin O.
[0019] Compound 14 is a molecule with active hydroxyl and allyl ester, which is ready for the subsequent esterification reaction. Compound 9 and compound 10 are condensed to generate compound 14, which introduces an active site. Compound 14 provides an ideal intermediate for the subsequent esterification reaction in terms of structure.
[0020] Compound 18 contains an active carboxylic acid group, which is ready for the subsequent esterification reaction. Compounds 15 and 16 are synthesized into compound 18 through a dehydration cyclization reaction. The dehydration cyclization reaction not only effectively introduces a five-membered ring structure, but also provides a key carboxylic acid group for the next esterification reaction. This group plays an important role in the formation of the final product lyngbyabellin O.
[0021] In the final synthetic step, compounds 14 and 18 were esterified to form an intermediate, which was then esterified by compound 8 to finally generate the target product compound 22, lyngbyabellin O. Through the two-step esterification reaction, multiple active groups were successfully connected to form a complex natural ester structure. The final compound 22 (lyngbyabellin O) retained the expected natural product structure, demonstrating the effectiveness and efficiency of the synthetic route.
[0022] (1) Synthesis of compound 8.
[0023] In one embodiment, the synthesis steps are as follows: S1.1. Compound 2 and compound 4 are mixed in an alkaline environment, and a catalyst is added to obtain compound 5.
[0024] The use of alkaline environment and catalyst ensures the efficient esterification reaction and reduces the formation of by-products. This step is particularly important in controlling unnecessary side reactions. This step successfully combines the two precursor molecules to generate compound 5 with the target functional group, providing the necessary intermediates for subsequent reactions.
[0025] Wherein, the preparation steps of compound 2 include: Compound 1 is placed in an alkaline environment to undergo a substitution reaction with methyl iodide to generate a methyl ester group.
[0026] Diethylamine was added to compound 1 to remove the protecting group to generate compound 2.
[0027] The use of diethylamine allows the efficient removal of the Fmoc (nonafluorene methoxycarbonyl) protecting group and the S-trityl protecting group to generate the target compound 2. The removal of the protecting group is to expose the active site required for the reaction. The substitution reaction with iodomethane successfully introduces the methyl ester group into the molecular structure, providing a key reaction site for the subsequent esterification reaction.
[0028] S1.2. Compound 5 is subjected to dehydration cyclization reaction to obtain compound 6.
[0029] The dehydration cyclization reaction generates a five-membered ring structure, which is a key structural transformation step that gives compound 6 special stereochemical properties. This ring structure provides a rigid framework for subsequent reactions and also enables the molecule to have the geometric configuration required for further reactions. Through the cyclization reaction, the molecular structure changes from linear to cyclic, significantly increasing the complexity and functionality of the molecule and preparing for subsequent oxidation and dihydroxylation reactions.
[0030] S1.3. Compound 6 is first oxidized to compound 7, and then compound 7 is subjected to an asymmetric dihydroxylation reaction to generate compound 8.
[0031] The process of oxidizing compound 6 to compound 7 is a key functional group transformation step. Through oxidation, hydroxyl groups or other oxidizing groups are introduced, providing the necessary precursor structure for the subsequent asymmetric dihydroxylation reaction. This step achieves the bifunctionalization of the molecule by introducing two hydroxyl groups, and the reaction is stereoselective, ensuring that the generated compound 8 has a specific stereochemical configuration. This is crucial for the biological activity of the molecule and further chemical modification. The realization of the asymmetric dihydroxylation reaction makes the final product compound 8 have high stereoselectivity, which is an important step in the synthesis of the target natural product.
[0032] In another embodiment, the steps of synthesis are as follows: After compound 25 is dissolved, triethylamine is added, and then a chloromethylation reagent is added to obtain compound 26.
[0033] Compound 25 was successfully converted to compound 26 through chloromethylation reaction, introducing a chloromethyl group, which provided an active center for the subsequent nucleophilic substitution reaction. The use of triethylamine effectively neutralized the generated acidic byproducts, improved the yield and selectivity of the reaction, and ensured the successful introduction of the chloromethyl group.
[0034] Compound 27 reacts with compound 26 to undergo nucleophilic substitution reaction to obtain compound 28.
[0035] Compound 27 acts as a nucleophile to undergo substitution reaction with the chloromethyl group in compound 26 to generate compound 28. By selecting appropriate reaction conditions, high selectivity of the reaction is ensured and the formation of by-products is avoided. By introducing a chloroalkyl group, compound 28 obtains a more complex molecular structure, which provides the necessary basis for subsequent oxidation reactions.
[0036] Compound 28 is dissolved in an inert solvent, and an oxidizing agent is added to convert the chloro group into a hydroxyl group to obtain Compound 8.
[0037] By selecting the appropriate oxidant and reaction conditions, the chloro group in compound 28 was successfully converted to a hydroxyl group. This oxidation reaction was not only a functional group conversion, but also significantly increased the polarity and activity of the molecule, providing possibilities for subsequent applications. The oxidation reaction in this step successfully generated the target compound 8, ensuring that the structure and function of the product met expectations. Stereoselective control in this process is also crucial to ensure that the generated compound has the correct configuration.
[0038] Wherein, the steps of preparing compound 25 include: L-ethionine and ethyl cyanoacetate are dissolved in anhydrous ethanol, and an alkaline reagent is added to carry out heating reaction to generate compound 3.
[0039] The use of alkaline reagents activated the reaction substrates, allowing L-ethionine and ethyl cyanoacetate to effectively condense to generate compound 3. Anhydrous ethanol as a solvent helps to increase the speed and yield of the reaction and prevent side reactions caused by moisture. Through this step of condensation reaction, the target intermediate compound 3 was successfully generated, laying the foundation for subsequent reaction steps.
[0040] The alkaline reagent for the condensation reaction can be sodium hydroxide, potassium carbonate, potassium hydroxide, or triethylamine.
[0041] Compound 3 was dissolved in anhydrous methanol, and an acidic reagent was added to carry out a heating reaction. After the reaction was completed, an alkaline reagent was added to neutralize the reaction to obtain compound 25.
[0042] Under an acidic environment, the carboxylic acid group in compound 3 undergoes an esterification reaction with methanol to generate a methyl ester group, thereby converting it into compound 25. The key to this step is to control the reaction conditions to ensure efficient esterification while avoiding the formation of by-products. After the reaction is completed, by adding an alkaline reagent to neutralize the reaction mixture, the remaining acidic reagent can be effectively neutralized to prevent degradation or further reaction of the product. This step improves the stability and purity of the product. Through this series of reactions, the target compound 25 was successfully generated, ensuring its structural integrity and functionality, especially the formation of carboxylic acid esters, making the compound suitable for further chemical modification or reaction.
[0043] The acidic reagent can be hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, zinc chloride.
[0044] The alkaline agent for the neutralization reaction can be sodium carbonate, sodium bicarbonate, or sodium hydroxide.
[0045] (2) Synthesis of compound 14.
[0046] S2.1. Add Lewis acid to compound 9 and compound 10 to carry out condensation reaction to obtain compound 11.
[0047] Lewis acid, as a catalyst, can effectively activate carbon groups, allowing compounds 9 and 10 to condense efficiently, thereby forming a new CC bond. The creativity of this step lies in the ability to generate compound 11 with high selectivity and avoid the formation of by-products. The generation of compound 11 is a key step in subsequent chemical reactions, which provides an active center and stereoselectivity for further molecular modification.
[0048] S2.2. Add diethyl azodicarboxylate, triphenylphosphine and p-nitrobenzoic acid to compound 11 in sequence to carry out a bimolecular nucleophilic substitution reaction to obtain compound 12.
[0049] The combination of diethyl azodicarboxylate and triphenylphosphine plays a key role in this reaction. They promote the substitution of the hydroxyl group in compound 11 by forming a Wittig intermediate, thereby introducing a p-nitrobenzoic acid group to generate compound 12. This reaction is highly selective and has a high yield. The reaction in this step introduces a p-nitrobenzoic acid group, which significantly increases the complexity and functionality of the molecule, making compound 12 potential for further modification.
[0050] S2.3. Add lithium hydroxide and hydrogen peroxide to compound 12 to remove the chiral auxiliary group and perform ester hydrolysis to obtain compound 13.
[0051] The combined use of lithium hydroxide and hydrogen peroxide can effectively remove the chiral auxiliary group in compound 12 while keeping the other functional groups in the molecule intact. This process is crucial to ensure that the generated compound 13 has the expected stereochemical configuration. While removing the chiral auxiliary group, the ester group is also hydrolyzed to generate a free carboxylic acid group, which provides compound 13 with a new reaction site and provides the possibility for subsequent reactions.
[0052] S2.4. Add allyl bromide and potassium bicarbonate to compound 13 to obtain compound 14.
[0053] Through the reaction of allyl bromide and potassium bicarbonate, an allyl group was successfully introduced into the molecule to generate compound 14. The introduction of the allyl group provides further functionalization possibilities for the molecule, especially in the subsequent possible cross-coupling reactions or other cyclization reactions. The generation of compound 14 not only increases the complexity of the molecule, but also lays the foundation for further chemical modification, enabling it to be used in more complex synthetic strategies.
[0054] (3) Synthesis of compound 18.
[0055] S3.1. Dissolve compound 15 and compound 16, add triethylamine, and stir to react.
[0056] As an alkaline reagent, triethylamine can neutralize the acidic components in the reaction system and ensure that the reaction is carried out under suitable alkaline conditions. This step helps to promote the reaction of compounds 15 and 16 and avoid side reactions that may occur in an acidic environment. Under the action of triethylamine, the reaction between compounds 15 and 16 can proceed smoothly to generate intermediates, laying the foundation for subsequent reactions. The use of triethylamine can also avoid the degradation of reactants or intermediates.
[0057] S3.2. Add acetonitrile and manganese dioxide, heat and stir, filter, wash and concentrate in sequence to obtain compound 17.
[0058] Manganese dioxide, as an oxidant, can effectively promote the reaction, particularly in the step of oxidation. Acetonitrile, as a solvent, provides good solubility for the reaction and maintains chemical stability at high temperatures. Heating and stirring helps to accelerate the reaction rate and improve the yield of the reaction. Subsequent filtering, washing and concentration steps ensure the purity and yield of the product and remove impurities and unreacted substances in the reaction. The implementation of this step successfully generates compound 17, laying the foundation for subsequent hydrolysis reactions.
[0059] S3.3. Compound 17 is mixed with lithium hydroxide solution to carry out hydrolysis reaction to generate compound 18.
[0060] As an alkaline reagent, lithium hydroxide can efficiently hydrolyze the ester group in compound 17 to generate the corresponding carboxylic acid compound 18. The choice of lithium hydroxide helps to control the selectivity and rate of the reaction and ensure the completeness of the hydrolysis reaction. The carboxylic acid group in compound 18 provides an important reaction site for further reactions, enabling it to undergo a variety of chemical modifications in subsequent synthetic steps.
[0061] (4) Synthesis of compound 22.
[0062] S4.1. Add N,N'-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) to compound 14 and compound 18 to carry out esterification reaction to generate compound 19.
[0063] DCC, as a dehydrating agent, can effectively promote the formation of ester bonds, while DMAP, as a catalyst, can improve the selectivity and efficiency of the reaction. This reaction successfully connected compounds 14 and 18 to generate the target compound 19. By using a combination of DCC and DMAP, this step can generate compound 19 with higher selectivity and yield, reducing the occurrence of side reactions.
[0064] S4.2. Add tetrakistriphenylphosphine palladium and morpholine to compound 19 to remove the allyl ester to obtain compound 20.
[0065] Tetrakistriphenylphosphine palladium as a catalyst can efficiently remove the allyl ester group, while morpholine helps to promote this process. This reaction ensures the integrity of other sensitive functional groups and only selectively removes the allyl ester protecting group to generate compound 20. By removing the allyl ester protecting group, the carboxylic acid group in compound 20 is exposed, preparing for the subsequent esterification reaction.
[0066] S4.3, compound 20 and compound 8 undergo esterification reaction to obtain compound 21.
[0067] The esterification reaction successfully connected the carboxylic acid group in compound 20 with the hydroxyl group in compound 8 to generate the complex compound 21. This reaction not only successfully constructed the ester bond, but also further improved the complexity and functionality of the molecule. By rationally selecting the reaction conditions, the efficient esterification reaction was ensured, allowing compound 21 to be produced in high yield and purity.
[0068] S4.4. Add trifluoroacetic acid to compound 21 to remove the protecting group to obtain compound 22.
[0069] Trifluoroacetic acid is a commonly used acidic reagent that can effectively remove a variety of protecting groups, especially those on hydroxyl and amino groups. This reaction ensures the high purity of compound 22 while maintaining the integrity of other functional groups. By removing the protecting groups, compound 22 was successfully obtained in its final form, demonstrating the integrity and effectiveness of the synthesis.
[0070] The present invention has been tested for many times, and some test results are now cited as references to further describe the invention in detail, and the following is a detailed description in conjunction with specific embodiments.
[0071] Embodiment 1: The reaction raw material compound 1 (5.0 g, 8.5 mmol) was weighed into a round-bottom flask, and DMF (15 mL, 0.57M) was added. K2CO3 (1.3 g, 9.3 mmol) was added under ice bath conditions. After stirring at room temperature for 30 min, MeI (1 mL, 17 mmol) was added. Stir at room temperature for 1 h. The reaction was complete by thin layer chromatography (TLC). The solvent was evaporated under reduced pressure, and the crude reaction mixture without purification was directly used for the next reaction.
[0072] The crude product was dissolved in acetonitrile (60 mL) and diethylamine solution (51 mL, 6 mL / mmol) was added dropwise. Stir at room temperature for 30 min and monitor the reaction by TLC to ensure that the 9-fluorenylmethoxycarbonyl (Fmoc) protecting group was completely removed. The solvent was evaporated under reduced pressure, the reaction mixture was concentrated, and purified by column chromatography (PE / EA, 3 / 1, v / v) to obtain compound 2 (2.9 g, 90%) as an orange oily liquid.
[0073] TLC:R f = 0.3 (PE / EtOAc = 3 / 1), ninhydrin was used for color development. =24.5 (c 0.8, CHCl3). 1HNMR (400 MHz, Chloroform- d ) δ 7.46 – 7.17 (m, 15H), 3.66 (s, 3H), 3.20 (dd, J =7.8, 4.8 Hz, 1H), 2.68 – 2.42 (m, 2H). 13 C NMR (101 MHz, Chloroform- d ) δ 174.1,144.5, 129.6, 127.9, 126.8, 66.8, 53.7, 52.1, 36.9. Embodiment 2: Compound 2 (2 g, 5.3 mmol) was weighed into a 100 mL single-necked round-bottom flask, the atmosphere was replaced with nitrogen, 34 mL of DCM was added to dissolve, 3,3-dimethylacrylic acid (4) (795 mg, 7.9 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) (1.2 g, 6.4 mmol), 1-hydroxybenzotriazole (HOBt) (1.0 g, 6.4 mmol) and DIPEA (1.84 mL, 10.6 mmol) were injected, and the reaction was stirred at room temperature overnight. After the reaction was completed under TLC monitoring, the product was diluted with EA and washed with 1 M aq. NH4Cl, distilled water, saturated sodium bicarbonate solution, water and saturated brine respectively. The organic phase was collected, dried over anhydrous sodium sulfate, filtered, and the solvent in the filtrate was removed by distillation under reduced pressure. Column chromatography (PE / EA, 5 / 1, v / v) was used to obtain compound 5 (2.07 g, 85%).
[0074] TLC:R f = 0.3 (PE / EtOAc = 4 / 1), ninhydrin color development, =4.6 (c 0.9, CHCl3) 1 HNMR (400 MHz, Chloroform- d ) δ 7.48-7.20 (m, 15H), 6.06 (d, J = 7.8 Hz, 1H), 5.59 (s, 1H), 4.73-4.69 (m, 1H), 3.70 (s, 3H), 2.73 (d, J = 1.6 Hz, 2H), 2.18(s, 3H), 1.87 (s, 3H). 13 C NMR (100 MHz, Chloroform-d ) δ 171.2, 166.1, 152.3,144.3, 129.4, 127.9, 126.8, 117.9, 66.8, 52.5, 50.8, 33.9, 27.2, 19.9. Embodiment 3: Weigh compound 5 (2.7 g, 5.9 mmol) in a 250 mL single-necked round-bottom flask, replace nitrogen, and add 150 mL of DCM to dissolve. Add 1 M TiCl4 (29.4 mL, 29.4 mmol) to the reaction bottle in an ice bath, slowly return to room temperature, and continue to stir the reaction overnight. After the reaction is completed by TLC monitoring, add saturated sodium bicarbonate solution to the reaction solution to quench, and then extract the aqueous phase with DCM. The organic phase is collected, dried over anhydrous sodium sulfate, and filtered. Collect the filtrate and concentrate to obtain 3.10 g of crude product. Column chromatography (PE / EA, 8 / 1, v / v) gives compound 6 (744 mg, 58 %).
[0075] TLC:R f =0.7 (PE / EA, 8 / 1), UV fluorescence & phosphomolybdic acid colorimetry. =21.1 (c 1.1,CHCl3). 1 H NMR (400 MHz, Chloroform- d ) δ 6.06 (s, 1H), 5.11 (t, J = 9.1 Hz, 1H), 3.80 (s, 3H), 3.47-3.59 (m, 2H), 2.09 (s, 3H), 1.89 (s, 3H). 13 C NMR (100 MHz, Chloroform- d ) δ 171.8, 168.4, 148.6, 119.0, 52.8, 35.5, 27.6, 20.9. Embodiment 4: Weigh compound 6 (640 mg, 3.21 mmol) into a 100 mL single-necked round-bottom flask, replace nitrogen, and add 35 mL of DCM to dissolve. Under ice bath conditions, add 1,8-diazobispiro[5.4.0]undec-7-ene (DBU) (0.54 mL, 3.53 mmol) and BrCCl3 (0.32 mL, 3.21 mmol) to the reaction solution. Slowly return to room temperature and continue stirring the reaction overnight at room temperature. After the reaction is completed by TLC monitoring, add saturated ammonium chloride solution to the reaction solution to quench, then use EA to extract the aqueous phase, collect the organic phase, dry it with anhydrous sodium sulfate, and filter it. Collect the filtrate, remove the solvent in the filtrate by vacuum distillation, and obtain compound 7 (538 mg, 85%) by column chromatography (PE / EA, 10 / 1, v / v).
[0076] TLC:R f = 0.37 (PE / EA, 8 / 1, v / v), UV fluorescence & phosphomolybdic acid colorimetry. 1 H NMR (400 MHz, Chloroform- d ) δ 8.04 (s, 1H), 6.58 (s, 1H), 3.88 (s, 3H), 2.08 (s, 3H), 1.94 (s, 3H). 13 C NMR (100 MHz, Chloroform- d ) δ 166.2, 162.1, 146.3, 144.3, 126.3,119.4, 52.4, 27.6, 20.8. Embodiment 5: Weigh MeSO2NH2 (1.5 g, 15.3 mmol), AD-mix-β (10 g, 7.50 mmol), and NaHCO3 (3.91 g, 45.96 mmol) in a 250 mL single-necked round-bottom flask, and then add 70 mL t -BuOH and 70 mL H2O, stirred until the solid was completely dissolved, added compound 7 (1.5 g, 5.13 mmol), purged with nitrogen, and reacted in an ice bath for 48 h. After the reaction was completed by TLC monitoring, the solvent was removed by vacuum distillation, and compound 8 (1.20 g, yield 96%) was obtained by column chromatography.
[0077] TLC:R f = 0.15 (PE / EA=1 / 1).TLC:R f= 0.15 (PE / EA=1 / 1), UV fluorescence & phosphomolybdic acid color development. = -3.3 (c 0.75, MeOH). 1 H NMR (400 MHz, Chloroform- d ) δ 8.17 (s, 1H), 4.84 (s, 1H), 3.94 (s, 3H), 1.34 (s, 3H), 1.20 (s, 3H). 13 C NMR (100 MHz, Chloroform- d ) δ 173.1, 162.0 146.0, 128.4, 77.7, 52.6, 25.6, 25.2. Embodiment 6: Under argon atmosphere, at -78°C, anhydrous DCM (90 mL) was injected into a 250 mL single-necked round-bottom flask, and compound 10 (1.4 mg, 6 mmol), 1.0 M Bu2BOTf (10.2 mL, 10.2 mmol) and triethylamine (1.5 mL, 10.8 mmol) were added to the stirred solution in sequence. The mixture was stirred at -78°C for 30 min, and then stirred at 0°C for 1 h. The mixture was cooled to -78°C again for 30 min, and a solution of compound 9 (1.22 g, 7.2 mmol) dissolved in anhydrous DCM (5 mL) and pre-cooled for 30 min was added, and stirred at -78°C overnight. After the reaction was complete as monitored by TLC, the reaction mixture was diluted with 0.5 M phosphate buffer (pH=7, 14 mL) and MeOH (45 mL), 30% H2O2 (7.5 mL) at -78°C, stirred at 0°C for 1 h, and the mixture was concentrated, and the resulting aqueous solution was extracted with DCM. The mixture was washed with brine solution, dried over anhydrous Na2SO4, filtered and concentrated, and column chromatography (PE / EA, 10 / 1, v / v) was performed to obtain a light yellow oily liquid compound 11 (1.86 g, 77%).
[0078] TLC:R f = 0.3 (PE / EtOAc = 10 / 1), UV fluorescence & phosphomolybdic acid color development. =-7.84 (CHCl3,1.0). 1 H NMR (400 MHz, Chloroform- d) δ 7.49 – 7.24 (m, 5H), 5.69 (d, J J = 7.3 Hz,1H), 4.80 (p, J J = 6.7 Hz, 1H), 4.00 (ddd, J J = 9.1, 3.8, 2.7 Hz, 1H), 3.79 (qd, J J =7.0, 2.7 Hz, 1H), 2.31 – 2.20 (m, 2H), 2.15 (s, 3H), 1.91 (ddtd, J J = 17.8, 9.8,8.0, 7.3, 5.1 Hz, 1H), 1.81 – 1.69 (m, 1H), 1.62 (dtd, J J = 14.6, 9.3, 5.0 Hz,1H), 1.47 (dddd, J J = 13.7, 9.9, 5.9, 3.7 Hz, 1H), 1.26 – 1.24 (m, 3H), 0.89 (d, J J = 6.6 Hz, 3H). 13 13C NMR(101 MHz, Chloroform- d ) δ 177.2, 152.6, 133.0, 128.9,128.8, 125.6, 90.6, 78.9, 71.3, 54.7, 49.5, 42.4, 37.2, 33.1, 22.5, 14.4,10.4.HRMS (ESI)Calcd for: C 19 H 25 Cl2NO4Na + [M + Na] + Calcd: 424.1161; found:424.1162. Example 7: Compound 11 (300 mg, 0.75 mmol) was weighed into a 25 mL single-necked round-bottom flask, and 25 mL THF was added to dissolve it. Diethyl azodicarboxylate (DEAD) (1.17 mL, 7.5 mmol), triphenylphosphine (1.96 g, 7.5 mmol) and p-nitrobenzoic acid (747.6 mg, 4.5 eq) were added in an ice bath, and stirred at room temperature for 3 hours. After the reaction was completed as monitored by TLC, the solvent was removed from the filtrate by vacuum distillation, and column chromatography (PE / EA, 5 / 1, v / v) was performed to obtain a light yellow oily liquid compound 12 (330 mg, yield 80%).
[0079] Compound 12 (320 mg, 0.58 mmol) was placed in a 100 mL single-necked round-bottom flask, and 4∶1 = THF:H2O (30 mL) was added. At 0°C, 30% H2O2 aqueous solution (0.31 mL, 2.32 mmol) and 5 M LiOH aqueous solution (0.35 mL, 1.74 mmol) were added, and the mixture was stirred overnight at room temperature. After the reaction was completed as monitored by TLC, Na2S2O4 aqueous solution (0.75 M, 1.9 mL) was added and washed with CH2Cl2. The aqueous phase was collected, and the aqueous layer was acidified with 6 M HCl (ca. pH=1), and extracted with CH2Cl2. The organic phase was collected, dried over anhydrous sodium sulfate, filtered, and concentrated. Compound 13 was obtained and directly used for the next step without purification.
[0080] Compound 13 was placed in a 100 mL single-necked round-bottom flask, anhydrous DMF (4 mL) was added, KHCO3 (120 mg, 1.2 mmol) and allyl bromide (0.07 mL, 0.81 mmol) were added under ice bath conditions, nitrogen was blown, a nitrogen balloon was tied, and the mixture was stirred at room temperature overnight. After the reaction was complete as monitored by TLC, it was diluted with ether, extracted with 1 M KHSO4, H2O, sat. aq. Na2SO3, H2O and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The solvent was removed from the filtrate by vacuum distillation, and column chromatography (PE / EA, 5 / 1, v / v) was performed to obtain a light yellow oily liquid compound 14 (84 mg, 40%).
[0081] TLC:R f = 0.3 (PE / EtOAc = 3 / 2), ninhydrin was used for color development. =-3.3 (c 0.75, CHCl3). 1 HNMR (400 MHz, Chloroform- d ) δ 5.92 (ddt, J= 17.2, 10.4, 5.7 Hz, 1H), 5.38 –5.23 (m, 2H), 4.62 (d, J = 5.7 Hz, 2H), 3.72 (d, J = 8.3 Hz, 1H), 2.57 (dd, J =7.3, 6.4 Hz, 1H), 2.22 (dd, J = 5.6, 1.7 Hz, 2H), 2.15 (s, 3H), 1.88 (dd, J =10.0, 5.3 Hz, 1H), 1.80 – 1.71 (m, 1H), 1.60 – 1.47 (m, 2H), 1.24 (d, J = 7.2Hz, 3H). 13 C NMR (101 MHz, Chloroform- d ) δ 175.6, 131.8, 118.6, 90.5, 73.0,65.3, 49.5, 45.2, 37.3, 33.8, 21.9, 14.4.HRMS (ESI)Calcd for: C 12 H 20 Cl2O3Na + [M+ Na] + Calcd: 305.0789; found: 305.0781. Embodiment 8: Will( S )-Cysteine ethyl ester hydrochloride compound 15 (5 g, 27 mmol) was placed in a 250 mL single-necked round-bottom flask, ethanol (90 mL) was added, and triethylamine (3.2 mL, 29.7 mmol) was added under ice bath. R )-(+)-Glyceraldehyde acetone compound 16 (3.36 g, 25.9 mmol) was dissolved in ethanol (100 mL) and added to the reaction flask. Stir at room temperature for 5 h. The reaction was complete after monitoring by TLC. The solvent was evaporated under reduced pressure. The crude product was dissolved in ether and washed with water (30 mL) and brine (20 mL). The organic phase was collected and washed with brine to remove excess water from the organic phase. The organic phase was dried over anhydrous sodium sulfate and filtered with absorbent cotton. The crude product was directly used for the next step without purification.
[0082] The crude product was added to CH3CN (150 mL), and MnO2 (30.2 g, 540 mmol) was added, and the mixture was heated and stirred at 60°C for 48 h. The reaction was complete by TLC monitoring. The crude mixture was filtered on diatomaceous earth. The organic phase was collected, washed with brine, filtered, concentrated, and column chromatography (PE / EA, 7 / 3, v / v) was performed to obtain a light yellow oily liquid compound 17 (3.2 g, two-step yield 46%).
[0083] TLC:R f = 0.3 (hexanes / EtOAc = 3 / 1), UV fluorescence & phosphomolybdic acid color development. = +15.3 (c1.02, CHCl3). 13 CNMR (101 MHz, Chloroform- d ) δ 8.13 (s, 1H), 5.41 (dd, J = 6.8,5.0 Hz, 1H), 4.46 – 4.38 (m, 3H), 4.08 (dd, J = 8.8, 5.0 Hz, 1H), 1.58 (s, 3H), 1.45 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H); 13 C NMR (101 MHz, Chloroform- d ) δ 172.8,160.5, 146.7, 126.9, 110.4, 74.7, 69.6, 60.6, 25.7, 24.4, 13.7. Embodiment 9: Compound 17 (500 mg, 1.94 mmol) was placed in a 100 mL single-necked round-bottom flask, methanol:THF=1:2 (20 mL) was added, and 0.5 M LiOH (7.8 mL, 7.8 mmol) solution was added dropwise. The mixture was stirred at room temperature for 3 hours. TLC monitored the reaction to be complete. Post-treatment: The organic phase was acidified with 1 M HCl (pH=2-3), extracted with EA, washed with brine, filtered, and concentrated. TLC: Rf = 0.3 (DCM / MeOH = 10 / 1), UV fluorescence & anisaldehyde color development. A pale yellow oily crude compound 18 was obtained, which was directly used in the next step without purification.
[0084] Fragment compound 14 (181 mg, 0.79 mmol) was added to a 50 mL single-necked round-bottom flask, and anhydrous toluene (7 mL) was added. Under ice bath conditions, 18 (204 mg, 0.72 mmol), DCC (179 mg, 0.87 mmol) and DMAP (106 mg, 0.87 mmol) were added, and the mixture was stirred at room temperature overnight. TLC monitored the reaction to be complete. Post-treatment: Toluene was concentrated under vacuum conditions, and column chromatography (PE / EA, 10 / 1, v / v) was performed to obtain a light yellow oily liquid compound 19 (285 mg, 80%).
[0085] TLC:R f = 0.3 (PE / EtOAc = 3 / 1), UV fluorescence & phosphomolybdic acid color development. =11.4 (c 1.2,CHCl3). 1 H NMR (400 MHz, Chloroform- d ) δ 8.09 (s, 1H), 5.85 (ddt, J = 17.2, 10.3,5.8 Hz, 1H), 5.42 – 5.36 (m, 2H), 5.33 – 5.23 (m, 1H), 5.17 (dq, J = 10.4, 1.3Hz, 1H), 4.56 (dq, J = 6.0, 1.2 Hz, 2H), 4.44 (dd, J = 8.8, 6.8 Hz, 1H), 4.13 –4.05 (m, 1H), 2.96 (p, J = 7.1 Hz, 1H), 2.33 – 2.12 (m, 2H), 2.10 (s, 3H), 1.86– 1.70 (m, 4H), 1.57 (s, 3H), 1.45 (s, 3H), 1.23 (d, J = 7.1 Hz, 3H). 13 C NMR (101MHz, Chloroform- d) δ 173.6, 172.8, 160.4, 146.9, 131.9, 127.8, 118.6, 111.2,90.2, 75.3, 75.1, 70.3, 65.4, 49.2, 43.2, 37.3, 30.5, 26.4, 25.0, 21.3,12.9.HRMS (ESI)Calcd for: C 21 H 29 Cl2NO6SNa + [M + Na] + Calcd:516.0992; found:516.0990. Embodiment 10: Dry a 50 mL single-necked round-bottom flask and replace the nitrogen. Pd(Ph3P)4 (8.3 mg, 0.007 mmol) was weighed into the reaction flask, the nitrogen was replaced, and a nitrogen balloon was tied. Under ice bath conditions, compound 19 (35 mg, 0.07 mmol) and morpholine (61 µL, 0.7 mmol) dissolved in dry THF (2 mL) were injected into the reaction flask. After stirring at room temperature for 15 minutes, TLC monitored the reaction to be complete. Post-treatment: dilute with ether, wash with 1M aq. KHSO4 and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the corresponding carboxylic acid compound 20. The crude product can be used in the next step without further purification.
[0086] The above carboxylic acid (30 mg, 0.066 mmol) was added to a 25 mL single-necked round-bottom flask, and toluene (5 mL) was injected. DMAP (4 mg, 0.033 mmol) and DIPEA (5.7 uL, 0.033 mmol) were added under ice bath conditions. After stirring at room temperature for 15 min, CSA (2.8 mg, 0.019 mmol), DCC (23 mg, 0.112 mmol) and 8 (17 mg, 0.072 mmol) were added under ice bath conditions. After stirring at room temperature for 5 hours, TLC monitoring showed that the reaction was complete. Post-treatment: concentration, column chromatography (DCM / MeOH, 100 / 1, v / v), purification, to obtain colorless oily liquid compound 21 (31 mg, 85%).
[0087] TLC:R f = 0.4 (DCM / MeOH = 30 / 1), UV fluorescence & phosphomolybdic acid color development. =-13.9 (c 1.0,CHCl3). 11H NMR (400 MHz, Chloroform- d ) δ 8.17 (d, J J = 5.6 Hz, 2H), 6.14 (s, 1H), 5.45 (dd, J J = 6.8, 4.8 Hz, 1H), 5.42 – 5.36 (m, 1H), 4.49 (dd, J J = 8.9, 6.8 Hz, 1H), 4.08 (dd, J J = 8.9, 4.8 Hz, 1H), 3.94 (s, 3H), 2.99 (dd, J J = 7.2, 4.4 Hz, 1H), 2.29 – 2.17 (m, 2H), 2.11 (s, 3H), 1.78 (s, 4H), 1.60 (s, 3H), 1.46 (s, 3H), 1.36 (s, 3H), 1.27 (d, J J = 7.0 Hz, 3H), 1.17 (s, 3H). 13 13C NMR (101 MHz, Chloroform-d) δ 174.9, 170.9, 167.5, 161.7, 160.9, 146.6, 146.1, 128.6, 128.5, 111.3, 90.1, 75.2, 75.0, 77.2, 71.7, 70.5, 52.5, 49.0, 43.7, 37.4, 31.4, 26.8, 26.4, 25.4, 25.0, 21.6, 13.6. HRMS (ESI) Calcd for: C 27 H 36 Cl2N2O9S2Na + [M + Na] + Calcd: 689.1239; found: 689.1230. Example 11: Carboxylic acid compound 21 (15 mg, 0.023 mmol) was added to a 10 mL single-necked round-bottom flask, and wet DCM (1 mL) was injected. TFA (50 µg, 0.67 mmol) was added under ice bath conditions. After stirring at room temperature for 2 hours, the reaction was completed after TLC monitoring. Post-treatment: concentration, scraping plate (DCM / MeOH, 10 / 1, v / v) purification, to obtain colorless oily liquid compound 22 (13 mg, 90%), namely lyngbyabellin O.
[0088] TLC:R f = 0.5 (DCM / MeOH =10 / 1), UV fluorescence & phosphomolybdic acid color development. =-11.0 (c 1.0,CHCl3). 1 H NMR (400 MHz, Chloroform- d ) δ 8.21 (s, 1H), 8.16 (s, 1H), 6.14 (s,1H), 5.46 – 5.36 (m, 1H), 5.08 (dd, J = 5.5, 4.0 Hz, 1H), 4.07 – 3.93 (m, 5H), 3.00 (dt, J = 7.2, 3.6 Hz, 1H), 2.31 – 2.19 (m, 2H), 2.12 (s, 3H), 1.80 (d, J =4.3 Hz, 4H), 1.40 (s, 3H), 1.29 – 1.23 (m, 6H), 1.18 (s, 3H). 13 C NMR (101 MHz, Chloroform- d ) δ 173.4, 170.9, 167.0, 161.7, 160.9, 146.1, 146.0, 129.0,128.8, 90.1, 75.1, 72.2, 71.8, 66.0, 52.5, 49.0, 43.8, 37.4, 31.5, 26.8,25.2, 21.6, 13.7.HRMS (ESI)Calcd for: C 24 H 32 Cl2N2O9S2Na + [M + Na] + Calcd:,6449.0826; found: 649.0821.
[0089] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a natural ester lyngbyabellin O, It is characterized in that the steps include: S1. preparing compound 8; S2, compound 9 and compound 10 undergo condensation reaction to obtain compound 14; S3, compound 15 and compound 16 undergo dehydration cyclization reaction to obtain compound 18; S4, the compound 14 and the compound 18 are first subjected to an esterification reaction, and then the compound 8 is added to carry out an esterification reaction to obtain the compound 22, wherein the compound 22 is a natural ester lyngbyabellin O; Wherein, the structural formula of the above compound is as follows: 、 、 、 、 、 、 、 。 2. The method for preparing the natural ester lyngbyabellin O according to claim 1, It is characterized in that The step S1 comprises: S1.1, mixing compound 2 and compound 4 in an alkaline environment, adding a catalyst, to obtain compound 5; S1.2, the compound 5 is subjected to a dehydration cyclization reaction to obtain a compound 6; S1.3, the compound 6 is first oxidized to form the compound 7, and then the compound 7 is subjected to an asymmetric dihydroxylation reaction to generate the compound 8; Wherein, the structural formula of the above compound is as follows: 、 、 、 、 。 3. The method for preparing the natural ester lyngbyabellin O according to claim 2, It is characterized in that The synthesis steps of compound 2 include: Compound 1 is placed in an alkaline environment to undergo a substitution reaction with methyl iodide to generate a methyl ester group; Add diethylamine to the compound 1 to remove the protecting group to generate the compound 2; Wherein, the structural formula of the above compound is as follows: 。 4. The method for preparing the natural ester lyngbyabellin O according to claim 1, It is characterized in that The step S1 comprises: After dissolving compound 25, triethylamine was added, and then a chloromethylation reagent was added to obtain compound 26; Compound 27 undergoes a nucleophilic substitution reaction with the compound 26 to obtain compound 28; Dissolving the compound 28 in an inert solvent, adding an oxidant to convert the chloro group into a hydroxyl group, thereby obtaining the compound 8; Wherein, the structural formula of the above compound is as follows: 、 、 、 。 5. The method for preparing the natural ester lyngbyabellin O according to claim 4, It is characterized in that The steps of preparing the compound 25 include: Dissolve L-ethionine and ethyl cyanoacetate in anhydrous ethanol, add an alkaline reagent and heat to react to generate compound 3; The compound 3 is dissolved in anhydrous methanol, an acidic reagent is added to carry out a heating reaction, and after the reaction is completed, an alkaline reagent is added to neutralize the reaction to obtain the compound 25; Wherein, the structural formula of the above compound is as follows: 。 6. The method for preparing the natural ester lyngbyabellin O according to claim 1, It is characterized in that The step S2 comprises: S2.1, adding Lewis acid to the compound 9 and the compound 10 to carry out a condensation reaction to obtain a compound 11; S2.2, adding diethyl azodicarboxylate, triphenylphosphine and p-nitrobenzoic acid to the compound 11 in sequence to carry out a bimolecular nucleophilic substitution reaction to obtain compound 12; S2.3, adding lithium hydroxide and hydrogen peroxide to the compound 12, removing the chiral auxiliary group and performing ester hydrolysis reaction to obtain compound 13; S2.4, adding allyl bromide and potassium bicarbonate to the compound 13 to obtain the compound 14; Wherein, the structural formula of the above compound is as follows: 、 、 。 7. The method for preparing the natural ester lyngbyabellin O according to claim 1, It is characterized in that The step S3 comprises: S3.1, dissolving and mixing the compound 15 and the compound 16, adding triethylamine, and stirring to react; S3.2, adding acetonitrile and manganese dioxide, heating and stirring, filtering, washing and concentrating in sequence to obtain compound 17; S3.3, mixing the compound 17 with a lithium hydroxide solution, and performing a hydrolysis reaction to generate the compound 18; Wherein, the structural formula of the above compound is as follows: 。 8. The method for preparing the natural ester lyngbyabellin O according to claim 1, It is characterized in that The step S4 comprises: S4.1, adding N,N'-dicyclohexylcarbodiimide and 4-dimethylaminopyridine to the compound 14 and the compound 18 to carry out an esterification reaction to generate a compound 19; S4.2, adding tetrakistriphenylphosphine palladium and morpholine to the compound 19, removing the allyl ester, and obtaining the compound 20; S4.3, the compound 20 and the compound 8 undergo esterification reaction to obtain compound 21; S4.4, adding trifluoroacetic acid to the compound 21 to remove the protecting group to obtain the compound 22; Wherein, the structural formula of the above compound is as follows: 、 、 。
